The Latest Cardiac and Vascular News
AB201 being developed as a potential treatment for COVID-19 and other RNA virus associated diseases ARCA anticipates filing an IND for AB201 in Q3 2020 and initiating Phase 2 clinical testing in Q4 2020 WESTMINSTER, Colo., Aug. 05, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a […]
– Phase 2b ADVISE trial evaluating etrasimod in atopic dermatitis (AD) enrollment complete, topline data expected Q4 2020 – Progressing first- or best-in-class drug candidates with liquidity position of ~$1.3bn as of June 30, 2020 SAN DIEGO, Aug. 5, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial […]
Submitted a New Drug Application to the U.S. Food and Drug Administration for the review of tenapanor as a first-in-class therapy to control serum phosphorus in adult patients with chronic kidney disease on dialysis Maintains strong balance sheet with $204.8 million in cash, cash equivalents and short-term investments FREMONT, Calif., Aug. […]
ATLANTA, Aug. 5, 2020 /PRNewswire/ — CorMatrix® Cardiovascular, Inc., (www.cormatrix.com) a leading developer of regenerative biomaterial compositions and medical devices, today announced European Patent Office patent claim allowances for European Community (EC) Patent Application Nos. 15 902 462.9 and 15 886 687.1, and U.S. Patent and Trademark Office patent claim allowance for U.S. Patent […]
– INXN-4001 delivered via retrograde coronary sinus infusion was well-tolerated in patients with chronic heart failure – – Preliminary data suggest an overall improvement in patient reported outcomes in 50% of patients six months after treatment – GERMANTOWN, Md., Aug. 6, 2020 /PRNewswire/ — Precigen Triple-Gene, a clinical stage cardiovascular gene therapy company […]
WYNNEWOOD, Pa., Aug. 6, 2020 /PRNewswire/ — Lankenau Heart Institute, part of Main Line Health, has named Basel Ramlawi, MD, the System Chief of Cardiac Surgery for Main Line Health and co-director of the Lankenau Heart Institute. Dr. Ramlawi brings nearly 20 years of complex and minimally invasive cardiovascular surgical experience to his new […]
CARLSBAD, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (NASDAQ: AFIB) today announced the pricing of its initial public offering of 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus. The […]
– As reported, revenues of $3.855 billion decreased 11.4 percent – On a currency-neutral basis, revenues decreased 9.4 percent – As reported, diluted earnings per share of $0.97 decreased 35.8 percent – As adjusted, diluted earnings per share of $2.20 decreased 28.6 percent or 25.0 percent on a currency-neutral basis […]
Funding to Support U.S. Pivotal Trial of CLAAS® Stroke Prevention Technology NASHUA, N.H., Aug. 6, 2020 /PRNewswire/ — Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation (AFib), today announced it has secured $85 million in Series C financing. The financing syndicate included participation from new investors Fidelity Management […]
EDEN PRAIRIE, Minn., Aug. 04, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the second quarter ended June 30, 2020, which included the following highlights: Revenue for the second quarter ended June 30, 2020, was $1.9 million, an increase of 14 percent from the […]
